Asian Institute of Nephrology and Urology 
Dealstreet

Khaitan advises Asian Institute of Nephrology and Urology on sale of majority stake to Asia Healthcare Holdings

The deal amount is valued at ₹600 crore.

Bar & Bench

The Asian Institute of Nephrology and Urology Private Limited ("AINU") has sold the majority stake by way of secondary sale and primary issuance of shares to Asia Healthcare Holdings Pte. Ltd. for an overall deal value of ₹600 crore.

Khaitan & Co advised AINU, the selling shareholders (including the promoters) and the exiting fund, HealthQuad Fund I in this transaction.

The core team consisted of Mayank Singh (Partner), Kevin Peter (Counsel), Kairavi Shah (Principal Associate), Esha Chauhan (Senior Associate), Hitakshi Mahendru (Senior Associate) with closing assistance from Mohnish Singh (Associate).

Mayank Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Employees hired without advertisement or interview cannot be regularised: Supreme Court

Constitution Amendment Bill to expand Lok Sabha strength to 850 fails to pass; Centre withdraws Delimitation Bills

Supreme Court grants relief to businessman Venu Gopalakrishnan in rape case filed by ex-employee

Nithin Raj suicide: Accused teachers move Kerala court for anticipatory bail

How India’s labour laws exclude ASHA, anganwadi and other workers by treating them as ‘volunteers’

SCROLL FOR NEXT